BioPharm International-01-01-2007

The HSV-1 and HVP-2 titers were determined by the inoculation of test solutions into Vero cell cultures and calculated using the Reed M?ench method.

Columns and Departments

January 01, 2007

China is home to more than 400 biogeneric manufacturers, which develop generic biopharmaceuticals for the domestic population.

Columns and Departments

January 01, 2007

The number of projects in Lonza's internal biomanufacturing pipeline grew by 40% to over 75 projects.

Columns and Departments

January 01, 2007

How much do regulatory agencies know about nanotechnology or microfluidics? Yesterday, the answer was probably, "not much." Tomorrow, it may be "a lot." The reason is that new technologies push the agencies to expand their expertise.

FDA is encouraging broader use of pharmacogenomic data by offering manufacturers early informal advice.

Columns and Departments

January 01, 2007

Given the complexity involved in the causes, mechanisms, and kinetics of protein aggregation, industry leaders and academics should continue to share knowledge and experience in this area.

The supply chain can be used as a tool for managing not only product supply risks, but overall business risks as well.

On a recent plane ride from Phoenix to Philly, I was leafing through a copy of the San Francisco Business Journal. I was taken aback by a story on the emerging trend of biopharm exchange-traded funds (ETFs), and how much of an impact they're having on Wall Street and on investors.

The Act will establish third party rights to challenge the validity of a patent through postgrant opposition proceedings.

The biotechnology industry is thriving, and hopefully you are too. BioPharm International's first salary and employee satisfaction survey presents a wealth of data that will allow you to compare many aspects of your job with those of your peers. The survey reports on demographics, education, work experience, salary and benefits, and attitudes toward current employment.